These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 11303913)

  • 1. CDK inhibitors suppress apoptosis induced by chemicals and by excessive expression of a cell death gene, reaper, in Drosophila cells.
    Nagano M; Ui-Tei K; Suzuki H; Piao Z; Miyata Y
    Apoptosis; 2000 Dec; 5(6):543-50. PubMed ID: 11303913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Roscovitine, olomoucine, purvalanol: inducers of apoptosis in maturing cerebellar granule neurons.
    Monaco EA; Beaman-Hall CM; Mathur A; Vallano ML
    Biochem Pharmacol; 2004 May; 67(10):1947-64. PubMed ID: 15130771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CDK-inhibitor olomoucine inhibits cell death after exposure of cell lines to cytosine-arabinoside.
    Papazisis KT; Geromichalos GD; Kouretas D; Dimitriadis KA; Kortsaris AH
    Cancer Lett; 1999 Apr; 138(1-2):221-6. PubMed ID: 10378797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p53-independent induction of apoptosis by cyclin-dependent kinase inhibition.
    Shibata Y; Nishimura S; Okuyama A; Nakamura T
    Cell Growth Differ; 1996 Jul; 7(7):887-91. PubMed ID: 8809406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of the cyclin-dependent kinase inhibitor olomoucine on cell cycle kinetics.
    Schutte B; Nieland L; van Engeland M; Henfling ME; Meijer L; Ramaekers FC
    Exp Cell Res; 1997 Oct; 236(1):4-15. PubMed ID: 9344580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell cycle arrest induced in human breast cancer cells by cyclin-dependent kinase inhibitors: a comparison of the effects exerted by roscovitine and olomoucine.
    Wesierska-Gadek J; Gueorguieva M; Wojciechowski J; Horky M
    Pol J Pharmacol; 2004; 56(5):635-41. PubMed ID: 15591654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cyclin-dependent kinase inhibitors olomoucine and roscovitine arrest human fibroblasts in G1 phase by specific inhibition of CDK2 kinase activity.
    Alessi F; Quarta S; Savio M; Riva F; Rossi L; Stivala LA; Scovassi AI; Meijer L; Prosperi E
    Exp Cell Res; 1998 Nov; 245(1):8-18. PubMed ID: 9828096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of cyclin-dependent kinase inhibitors on transcription and ocular circadian rhythm of Aplysia.
    Sankrithi N; Eskin A
    J Neurochem; 1999 Feb; 72(2):605-13. PubMed ID: 9930732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. G1/S cell cycle blockers and inhibitors of cyclin-dependent kinases suppress camptothecin-induced neuronal apoptosis.
    Park DS; Morris EJ; Greene LA; Geller HM
    J Neurosci; 1997 Feb; 17(4):1256-70. PubMed ID: 9006970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell cycle inhibitor enhances the resolution of HSV-1-induced proinflammatory response in murine microglial cells.
    Zhou Y; Guo YJ; Liu X; Mei YW
    Neurol Res; 2009 Nov; 31(9):910-6. PubMed ID: 19138471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cdk inhibitors, roscovitine and olomoucine, synergize with farnesyltransferase inhibitor (FTI) to induce efficient apoptosis of human cancer cell lines.
    Edamatsu H; Gau CL; Nemoto T; Guo L; Tamanoi F
    Oncogene; 2000 Jun; 19(27):3059-68. PubMed ID: 10871858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell differentiation, caspase inhibition, and macromolecular synthesis blockage, but not BCL-2 or BCL-XL proteins, protect SH-SY5Y cells from apoptosis triggered by two CDK inhibitory drugs.
    Ribas J; Boix J
    Exp Cell Res; 2004 Apr; 295(1):9-24. PubMed ID: 15051486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiproliferative effect of plant cytokinin analogues with an inhibitory activity on cyclin-dependent kinases.
    Vermeulen K; Strnad M; Krystof V; Havlícek L; Van der Aa A; Lenjou M; Nijs G; Rodrigus I; Stockman B; van Onckelen H; Van Bockstaele DR; Berneman ZN
    Leukemia; 2002 Mar; 16(3):299-305. PubMed ID: 11896531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenovirus-mediated E2F-1 gene transfer induces an apoptotic response in human gastric carcinoma cells that is enhanced by cyclin dependent kinase inhibitors.
    Atienza C; Elliott MJ; Dong YB; Yang HL; Stilwell A; Liu TJ; McMasters KM
    Int J Mol Med; 2000 Jul; 6(1):55-63. PubMed ID: 10851267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Caspase 8/10 are not mediating apoptosis in neuroblastoma cells treated with CDK inhibitory drugs.
    Ribas J; Gomez-Arbones X; Boix J
    Eur J Pharmacol; 2005 Nov; 524(1-3):49-52. PubMed ID: 16243312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The lethal effects of pharmacological cyclin-dependent kinase inhibitors in human leukemia cells proceed through a phosphatidylinositol 3-kinase/Akt-dependent process.
    Yu C; Rahmani M; Dai Y; Conrad D; Krystal G; Dent P; Grant S
    Cancer Res; 2003 Apr; 63(8):1822-33. PubMed ID: 12702569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cyclin-dependent kinase (cdk) inhibitors, olomoucine and roscovitine, alter the expression of a molluscan circadian pacemaker.
    Krucher NA; Meijer L; Roberts MH
    Cell Mol Neurobiol; 1997 Oct; 17(5):495-507. PubMed ID: 9353591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CDK inhibitors induce mitochondria-mediated apoptosis through the activation of polyamine catabolic pathway in LNCaP, DU145 and PC3 prostate cancer cells.
    Arisan ED; Obakan P; Coker-Gurkan A; Calcabrini A; Agostinelli E; Unsal NP
    Curr Pharm Des; 2014; 20(2):180-8. PubMed ID: 23701543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5.
    Meijer L; Borgne A; Mulner O; Chong JP; Blow JJ; Inagaki N; Inagaki M; Delcros JG; Moulinoux JP
    Eur J Biochem; 1997 Jan; 243(1-2):527-36. PubMed ID: 9030781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of X-ray and doxorubicin-induced apoptosis by butyrolactone I, a CDK-specific inhibitor, in human tumor cells.
    Lu Y; Takebe H; Yagi T
    J Radiat Res; 2000 Dec; 41(4):341-8. PubMed ID: 11329882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.